Covid-19: Rare immune response may cause clots after AstraZeneca vaccine, say researchers
- 12 April 2021
- other
- review article
- Published by BMJ
- Vol. 373, n954
- https://doi.org/10.1136/bmj.n954
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 VaccinationThe New England Journal of Medicine, 2021
- AstraZeneca vaccine: Blood clots are “extremely rare” and benefits outweigh risks, regulators concludePublished by BMJ ,2021